NC
NewcelX Ltd. (NCEL)
NASDAQ·Healthcare·Biotechnology
$3.24
-16.41%
Mkt Cap $1.23M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Oct 4, 2025 | — | — | — | — | -$5.54 | — | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$8.40 | -$0.00 | +100.00% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | -$6.80 | -$0.20 | +97.07% | — | — |
| Q2 2023 May 5, 2023 | — | — | — | -$12.00 | -$0.29 | +97.55% | — | — |
| Q4 2022 Oct 11, 2022 | — | — | — | — | -$0.54 | — | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | -$13.80 | -$0.50 | +96.39% | — | — |
| Q3 2021 Sep 28, 2021 | — | — | — | — | -$0.42 | — | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$6.80 | -$0.34 | +95.03% | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.11 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.18 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$0.31 | — | — | — |
| Q4 2018 Dec 31, 2018 | — | — | — | — | -$19.32 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | — | — | — | -$13.57 | — | — | — |
| Q2 2017 Jun 30, 2017 | — | — | — | — | -$0.16 | — | — | — |